序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
41 Pharmaceutical compositions and their preparation for the treatment of bronchitis JP2012517995 2009-06-30 JP5502197B2 2014-05-28 イーリン ウー; ヨンフェン チャン; ホンフイ シュー; シャオヤン リ; シュエリ ジ; シャオリ ウー; チャオ ワン; ユンペン リ; メン ワン
42 CONTROL OF MC-1R, MC-2R AND μ OPIOID RECEPTORS JP2013218869 2013-10-22 JP2014024860A 2014-02-06 PAIN SABINE; DEZUTTER COLETTE; ANDRE VALERIE; REYMERMIER CORINNE; ORLY ISABELLE; PERRIER ERIC
PROBLEM TO BE SOLVED: To provide a composition for cosmetics or skin care products in order to prevent and/or counter the influence of stress that induces skin aging and/or changes observed during the skin aging process, to prevent and/or counter the reduction of epidermic homeostasis, to promote epithelization, to improve cell proliferation and differentiation, to prevent and/or counter the decrease in cutaneous angiogenesis, to improve hyperpermeability of blood vessel, to prevent and/or counter cutaneous hypoinnervation, to improve cutaneous innervation, or to give satisfaction.SOLUTION: The composition for cosmetics or skin care products includes an extract of Oenothera biennis as an active component.
43 Adhesive intraoral patch with recess used in the oral cavity JP2013151530 2013-07-22 JP2013216692A 2013-10-24 HALEY JEFFREY T
PROBLEM TO BE SOLVED: To provide an intraoral patch having the form of glycyrrhetic acid being watersoluble at an intraoral temperature.SOLUTION: It is preferable to use an aqueous salt (SGE) of a glycyrrhizin licorice extract to obtain a high-volume uptake in a local tissue, or to obtain a high-efficacy as compared with a drug amount used (to minimize a risk of side effects). The SGE contains a group of chemical salts of glycyrrhetic acid, including potassium salt of the glycyrrhetic acid and alkalimetal salt of the glycyrrhetic acid.
44 Lipolysis accelerator JP2005177058 2005-06-16 JP5118292B2 2013-01-16 陽子 末竹; 圭司郎 吉田; 進 志村; 勉 荒川; 征大 谷
45 Oral patch containing a salt of glycyrrhetinic acid is water soluble at oral temperature, JP2009505479 2007-04-13 JP2009535304A 2009-10-01 ハーレイ,ジェフリー,ティー.
【解決課題】口内温度溶性であるグリシルレチン酸の形態の溶解性口内パッチが開示されている。
【解決手段】局部組織内への多量吸収、すなわち使用される薬剤量に比して薬効が高い治療(副作用のリスクを最低にする)のために、グリシルリチン甘草抽出物の水溶塩(SGE)を使用することが望ましい。 SGEは口内温度で水溶性である1群のグリシルリチン酸の化学塩を含む。 それらにはグリシルレチン酸のカリウム塩とグリシルレチン酸のアルカリ金属塩が含まれる。
【選択図】図2
46 Pharmaceutical composition comprising a lipase inhibitor and glucomannan JP2003587376 2003-04-15 JP4234017B2 2009-03-04 バイリー,ジャック; マルティン,ライナー・オイゲン; ラーブ,スザンヌ
47 Use of Maimo (konjac tubers) and its extract in formulating a medicament for the treatment of acute and chronic bronchitis JP2008508055 2006-04-25 JP2008539175A 2008-11-13 シュファ チュ
本発明は、急性および慢性気管支炎を治療するための医薬を調合する際の魔芋およびその抽出物の利用に関し、原材料として魔芋および五味子を含んでいる医薬品組成物に関し、その製造方法および医薬品組成物の使用に関する。
【選択図】図1
48 The use of plant extracts in the cosmetic composition JP2007548241 2005-11-28 JP2008525446A 2008-07-17 シー デュガン,ミッチェル; ディ ハインズ,ミッチェル; アール ビネッティ,ラルフ
【課題】皮下脂肪の減少を伴うエイジングの徴候例えば顔面の脂肪の減少および皮膚のたるみを治療、予防、縮小、阻害および/または改善する組成物の安全、有効かつ新しい成分を含む組成物の提供。
【解決手段】脂質の生成、アジポネクチンの生成、脂肪細胞の分化、PPAR−ガンマの誘導、および/またはこれらの任意の組み合わせを刺激するのに十分な化粧品上、皮膚科学上または製薬上有効な量の少なくとも1つの植物抽出物、並びに化粧品上、皮膚科学上または製薬上許容できる媒体からなる局所組成物。
【選択図】なし
49 Nicotine-removing gum composition JP2002269836 2002-09-17 JP2003212759A 2003-07-30 CHOI JIN HWAN; ROH HOE JIN; LEE KI JEONG; PARK CHEON HO; RHA CHAN SU
<P>PROBLEM TO BE SOLVED: To provide a nicotine-removing gum composition capable of reducing the nicotine content in a body by chewing the gum. <P>SOLUTION: This nicotine-removing gum composition comprises 0.01-10 wt.% of a substance having a nicotine removing activity, 50-89 wt.% of saccharides and 10-40 wt.% of a gum base. The gum produced from the composition has functions to convert a large amount of the nicotine absorbed in the body into cotinine after smoking and discharge the cotinine into urine. When the gum is chewed, not only the nicotine in the body can be removed but also the incidence rate of cancer with the nicotine can be reduced. <P>COPYRIGHT: (C)2003,JPO
50 Herbal extract composition having an immune-enhancing activity JP2000555627 1999-06-19 JP2002518454A 2002-06-25 アブダラー シェハデー,アーマド
(57)【要約】 本発明は、アルムエキス、ザクロエキス、フヨウエキス及びチャエキスを含有する草本エキス組成物に関する。 本組成物は、インビトロでリンパ球の芽球化及びサイトカイン生産を刺激し、そしてインビトロでgp120 の結合を阻害することが示され、従って、免疫障害及びHIV 感染の治療に有用で有り得る。
51 Plant extracts and their applications JP32068991 1991-12-04 JPH0647553B2 1994-06-22 貞助 文; 鴻基 景; 春元 金; 鐘培 金; 仁權 韓; 永▲福▼ 韓
52 토란 추출물을 활성성분으로 포함하는 약학 조성물 KR1020130118568 2013-10-04 KR1020130121783A 2013-11-06 신광순; 박혜령; 민병직; 김윤숙; 최희돈; 최인욱; 박용곤
The present invention relates to a pharmaceutical composition and health functional food comprising taro extract as an active ingredient, and the pharmaceutical composition and health functional food comprising taro extract by the present invention can be used as an anticancer medicine and an anti-metastasis treating agent by having an anti-complement activity function, a macrophage or a natural killer cell activity funftion, and thereby activating immune system and having effectively reduing spread of cancel cell.
53 천연식물을 이용한 공기 정화용 조성물의 제조 방법 KR1020120096154 2012-08-31 KR101286217B1 2013-07-16 임재철; 민병한
PURPOSE: A method for manufacturing compositions for air purification using natural plants is provided to manufacture compositions for air purification by pulverizing dried natural plants and extracting active ingredients from the pulverized natural plants. CONSTITUTION: A method for manufacturing compositions for air purification using natural plants comprises the following step. One or more dried natural plants prepared to purify air are pulverized and are made into powder (S101). The powder is mixed (S102). The mixed powder is extracted through an extraction solvent and the extracted natural plant extract is cooled (S103). A solid content included in the cooled natural plant extract is removed (S104). The solid content-removed natural plant extract is centrifuged (S105). The natural plant is one or more selected from a group comprising Philodendron domesticum, Araucaria, Maranta, and Anthurium. [Reference numerals] (AA) Start; (BB) End; (S101) Powder processing step; (S102) Mixing step; (S103) Extracting and cooling step; (S104) Solid powder removing step; (S105) Centrifuging step
54 기관지 천식의 예방과 치료를 위한 조성물 KR1020110120552 2011-11-18 KR1020130055059A 2013-05-28 신용국; 김현식; 김종진; 윤승원; 서상완; 오진해; 이창혁; 김송이; 김정훈; 신현화; 장은경; 정순모; 박기한; 조정기; 이지은; 김민선; 박규환
PURPOSE: A composition is provided to suppress NO generation without cytotoxicity, to suppress airway resistance, inflammatory materials, lung tissue protein STAT4 and STAT6, and T cell activation, and to increase anti-inflammatory materials. CONSTITUTION: A composition for preventing and treating bronchial asthma contains a mixture extract of Rehmannia glutinosa, Pinellia ternate, Citrus reticulate, Glycyrrhiza glabra, Platycodon grandiflorum, and Schizandra chinensis as an active ingredient. The mixture extract is prepared using 70% methanol. The daily dose of the mixture extract is 0.0001-10 mg/kg. A health functional food for preventing and treating bronchial asthma contains the mixture extract as an active ingredient. The health functional food further contains a sitologically acceptable food additive. [Reference numerals] (AA) Extraction with water, OMC 0.1mg/kg + OVA; (BB) Extraction with water, OMC 1mg/kg + OVA; (CC) Extraction with methanol, OMC 0.1mg/kg + OVA; (DD) Extraction with methanol, OMC 1mg/kg + OVA
55 토란 추출물을 활성성분으로 포함하는 약학조성물 KR1020110041035 2011-04-29 KR1020120122709A 2012-11-07 신광순; 박혜령; 민병직; 김윤숙; 최희돈; 최인욱; 박용곤
PURPOSE: A pharmaceutical composition and a health functional food containing taro extract for enhancing immune system are provided to be used as a therapeutic agent for anticancer and anti-metastasis. CONSTITUTION: A pharmaceutical composition for enhancing immune system contains polymer saccharides of chemical formula 1 as an active ingredient. A health functional food for enhancing immune system contains the polymer saccharides as an active ingredient. A pharmaceutical composition for anti-metastasis contains the polymer polysaccharides of chemical formula 1 as an active ingredient. A pharmaceutical composition for enhancing immune system contains taro exract as an active ingredient. The taro extract contains galactose and mannose. A health functional food for enhancing immune system contains the taro extract as an active ingredient.
56 AIDS 및 관련 상태의 치료용 조성물 KR1020107012737 2003-09-11 KR101017879B1 2011-03-04 아시드윌리엄; 아시드프레더릭; 엔닌매니; 도두마이클시아; 보텅찰스안트위; 아피아-쿠비콰시; 웨어세스오포쿠; 보텅데브라; 암핌코피; 오우수윌리엄; 어드제이어퀘트렉스
AIDS 및 AIDS 와 관련된 상태 치료 조성물이 개시된다. 상기 조성물은 하기 식물과 중 하나 이상의 추출물로부터 선택된 약제를 포함한다:
(1) 협죽도과 (플레이오스카르파 비카르펠라타); (2) 포포나무과 (클레이스토폴리스 파텐스); (3) 디카페탈라세아에 (디카페탈룸 마다가스카리엔스); (4) 아노세아에 (우바리아스트룸 피에레아눔); (5) 시노시나세아에 (스트로판투스 그라투스; Strophanthus Gratus); (6) 박주가리과 (곤그로네마 라티폴륨); (7) 사군자과 (콤브레툼 라세모섬); (8) 협죽도과 (알소토니아 불네이); (9) 비름과 (알테르난테라 푼겐스); (10) 아로세아에 (안코마네스 디페르미스); (11) 사초과 (셀레리아 보이비닐); (12) 옻나무과 (라네아 아시다; Lannea Acida); (13) 능소화과 (키겔리아 아프리카나); (14) 물밤나무과 (세이바 펜타노타; Ceiba Pentanota); (15) 옻나무과 (안트로카리온 미크라스터); (16) 물밤나무과 (봄박스 보우노포젠스); (17) 옻나무과 (스폰디아스 몸빈); (18) 카리카세아에 (카리카 파파야); (19) 임의의 상기 추출물의 글리세릴 에스테르; (20) 임의의 상기 추출물의 사포닌; (21) 임의의 상기 추출물의 알칼로이드; (22) 임의의 상기 추출물의 단백질; (23) 임의의 상기 추출물의 지방; (24) 임의의 상기 추출물의 당류; 및 (25) 임의의 상기한 것들의 임의의 혼합물.
57 AIDS 및 관련 상태의 치료용 조성물 KR1020097016128 2003-09-11 KR1020090099003A 2009-09-18 아시드윌리엄; 아시드프레더릭; 엔닌매니; 도두마이클시아; 보텅찰스안트위; 아피아-쿠비콰시; 웨어세스오포쿠; 보텅데브라; 암핌코피; 오우수윌리엄; 어드제이어퀘트렉스
An Aids and associated conditions related to Aids treating compositions is disclosed. The compositions comprises: a medicament selected from an extract of at lease one of the following plant families: (1.) Apocynaceae (Pleioscarpa Bicarpellata); (2) Annonaceae (Cleistopholis Patens); (3) Dichapetalaceae (Dichapetehan Madagasca Riense); (4) Annoceae (Uvaristrum Pierreanum); (5) Cynocynaceae (Strophantus Gratus); (6) Asclepiadaceae (Gongronema Latifolium); (7) Combretaceae (Combretum Racemosum); (8) Apocynaceae (Alsotonia boonei); (9) Amaranthaceae (Alternanthera Pungens); (10) Aroceae (Anchomanes Differmis); (11) Cyperaceae (Seleria Voivinil); (12) Anacardiaceae (Lannea Acida); (13) Bignoniaceae (Kigelia Africana); (14) Bombacaceae (Ceiba Pentanota); (15) Anarcardiaceae (Antrocaryon Micraster); (16) Bombacaceae (Bombax Bounopozense); (17) Anarcardiaceae (Spondias Mombin); (18) Caricaceae (Carica Papaya); (19) a glyceryl ester of any of the foregoing extracts; (20) a saponin of any of the foregoing extracts; (21) an alkaloid of any of the foregoing extracts; (22) a protein of any of the foregoing extracts; (23) a fat of any of the foregoing extracts; (24) a sugar of any of the foregoing extracts; and (25) any mixture of any of the foregoing.
58 지방분해 촉진제 및 이를 함유하는 비만 예방 및 개선용기능성 식품 KR1020060054103 2006-06-15 KR100813175B1 2008-03-17 스에타케요코; 요시다케이시로; 시무라스스무; 아라카와츠토무; 타니마사히로
본 발명은 지방분해 촉진제 및 이를 함유하는 비만 예방 및 개선용 기능성 식품에 관한 것으로서, 더욱 상세하게는 지방세포 중의 특히 중성지방 분해능이 탁월한 식물체를 검색하고 이들을 유효성분으로 함으로써, 축적된 지방조직의 분해를 촉진할 수 있고, 전신 또는 국소 지방을 감소시킬 수 있어 비만의 예방 및 개선에 유효하고 천연물 유래의 식물체를 사용하므로 안정성이 높은 신규한 지방분해 촉진제 및 이를 함유하는 비만 예방 및 개선용 기능성 식품에 관한 것이다. 지방분해, 지방세포, 중성지방, 비만
59 지방분해 촉진제 및 이를 함유하는 비만 예방 및 개선용기능성 식품 KR1020060054103 2006-06-15 KR1020060131684A 2006-12-20 스에타케요코; 요시다케이시로; 시무라스스무; 아라카와츠토무; 타니마사히로
Provided are a lipolysis booster and functional foods containing the same, which have a lipolysis-promoting action in fatty tissue and are effective in preventing or improving obesity. The lipolysis booster contains, as active components, one, two or more selected from myristica fragrens, Symplocarpus foetidus, California Poppy(Escholzia california), Sparganium stoloniferum, Sanguinaria canadensis, Oregon grape(Mahonia Aquifolium), Acorus gramineus, fruits of Musa paradiciaca, Cytisus scoparius, goldenseal(Hydrastis canadensis), Ficaria ranunculoides, fumitory(Fumaria officinalis), Icoja(Unonopsis floribunda), Nasturtium officinale, black cumin(Nigella sativa), nettle(Urtica dioica), Capsella bursa-pastoris, and Polygonumbistorta, and extracts thereof.
60 一种魔芋虫草菌丝体饮料酒的生产方法 CN201610438831.6 2016-06-20 CN107523457A 2017-12-29 莫沉鹏; 古伟尧
发明涉及一种魔芋虫草菌丝体饮料酒的生产方法,它是以魔芋虫草菌丝体红糯米、苦荞麦、酒曲、为原料,经精心发酵生产出保健饮料酒,具有“补泻”适当,排毒清肠胃、促进人机体组织的新陈代谢、防治心脑血管疾病及调节“三高”症状,实为中老年人不可多得的保健饮品。
QQ群二维码
意见反馈